| Treatment of Recalcitrant Medial and Lateral Epicondylitis with Autologous Platelet Rich Plasma; Preliminary Report |
|
Jong Ha Lee, Jun O Yoon, Bong Seong Jeong, Ho Youn Park |
1Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. joonoyoon@amc.seoul.kr
2Department of Woo & Lee's Institute for Hand Surgery & Reconstructive Microsurgery, W Hospital, Daegu, Korea. |
|
|
| Abstract |
Purpose
We evaluated the clinical outcomes of the autologous platelet rich plasma injection for the treatment of recalcitrant medial and lateral epicondylitis.
MATERIALS AND METHODS: Nineteen cases with recalcitrant medial and lateral epicondylitis despite of conservative treatment for 1 year were enrolled in this study. Each patient underwent autologous platelet rich plasma injection and followed up minimally of 40 weeks. The assessment included a preoperative and postoperative Visual Analogue Scale (VAS) (0~10) at 4, 8, 12, 24 and 36 weeks and overall satisfaction was evaluated with Roles & Maudsley score at 36 weeks after injection. We also compared the clinical outcomes between medial and lateral epicondylitis group.
Results
Mean preoperative VAS was 8.7 points and improved to 5.1, 5.2 and 4.7 at 12, 24 and 36 weeks follow up, respectively. Roles & Maudsley score was excellent in 5 cases(26%), good in 7 cases(37%), acceptable in 4 cases(21%) and poor in 3 cases(16%). On the comparison of medial and lateral epicondylitis group, there was no statistical significant difference (p=0.38).
Conclusion
The autologous platelet rich plasma injection for recalcitrant medial & lateral epicondylitis is thought to be a alternative treatment option. |
| |
|
PDF Links
Full text via DOI
Download Citation
